-
公开(公告)号:ZA9401902B
公开(公告)日:1994-10-14
申请号:ZA9401902
申请日:1994-03-17
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: PATEL DINESH V , KLINE TONI B , MEYERS CHESTER A , LEFTHERIS KATERINA , BHIDE RAJEEV S
IPC: A61K20060101 , C07C20060101 , A61K , C07C
-
公开(公告)号:ES2395038T3
公开(公告)日:2013-02-07
申请号:ES05803757
申请日:2005-06-30
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: LIN JAMES , WROBLESKI STEPHEN T , LIU CHUNJIAN , LEFTHERIS KATERINA
IPC: C07D487/14 , A61K31/53 , A61P3/10 , A61P9/04 , A61P19/02
Abstract: Un compuesto que tiene la fórmula (I):en la que:Q es arilo o heteroarilo, estando dicho arilo o heteroarilo opcionalmente sustituido con 0 a 2 R6, 5 0 a 2 R7 y 0 a 1R8;R1 es hidrógeno o alquilo C1-4;R2 y R4 se seleccionan independientemente entre hidrógeno, alquilo, alquilo sustituido, alquenilo, alquenilosustituido, halógeno, ciano, nitro, amino, alquilamino, hidroxilo, alcoxilo, alcoxilo sustituido, cicloalquilo,cicloalquilo sustituido, arilo, arilo sustituido, heterociclo, heterociclo sustituido , heteroarilo y heteroarilosustituido;R3 y R5 se seleccionan independientemente entre hidrógeno, alquilo, alquilo sustituido, alquenilo, alquenilosustituido, cicloalquilo, cicloalquilo sustituido, arilo, arilo sustituido, heterociclo, heterociclo sustituido, heteroariloy heteroarilo sustituido;R6, R7 y R8 se seleccionan en cada aparición independientemente entre hidrógeno, alquilo, alquilo sustituido,alquenilo, alquenilo sustituido, halógeno, ciano, nitro, -OR9, - SR9, -S(>=O)R11, -S(>=O)2R11, -P(>=O)2R10,-S(>=O)2OR11, -P(>=O)2OR10, -NR9R10, -NR9S(>=O)2R11, NR9P(>=O)2R10, -S(>=O)2NR9R10, -P(>=O)2NR9R10,-C(>=O)OR9, -C(>=O)R9, -C(>=O)NR9R10, -OC(>=O)R9, -OC(>=O)NR9R10, -NR9C(>=O)OR10, -NR12C(>=O)NR9R10,-NR12S(>=O)2NR9R10, -NR12P(>=O)2NR9R10, -NR9C(>=O)R10, -NR9P(>=O)2R10, cicloalquilo, cicloalquilo sustituido,arilo, arilo sustituido, heterociclo, heterociclo sustituido, heteroarilo y heteroarilo sustituido;R9, R10 y R12 se seleccionan independientemente en cada aparición entre hidrógeno, alquilo, alquilo sustituido,alquenilo, alquenilo sustituido, cicloalquilo, cicloalquilo sustituido, heterociclo, heterociclo sustituido, arilo, arilosustituido, heteroarilo y heteroarilo sustituido, o como alternativa, cuando R9 y R10 están unidos al mismo átomode nitrógeno, como en -NR9R10, se pueden tomar conjuntamente para formar un heterociclo, heteroarilo,heterociclo sustituido o heteroarilo sustituido;R11 se selecciona entre alquilo, alquilo sustituido, alquenilo, alquenilo sustituido, cicloalquilo, cicloalquilosustituido, heterociclo, heterociclo sustituido, arilo, arilo sustituido, heteroarilo y heteroarilo sustituido;y/o sales farmacéuticamente aceptable y/o isómeros del mismo.
-
公开(公告)号:AT522525T
公开(公告)日:2011-09-15
申请号:AT09010209
申请日:2004-05-03
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: DYCKMAN ALARIC , DAS JAGABANDHU , LEFTHERIS KATERINA , LIU CHUNJIAN , ZHAO RULIN , CHEN BANG-CHI , WROBLESKI STEPHEN T
IPC: C07D413/12 , A61K20060101 , A61K31/415 , A61K31/4152 , A61K31/4155 , A61K31/416 , A61K31/4245 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/535 , A61K31/675 , A61P37/00 , C07D20060101 , C07D231/04 , C07D231/14 , C07D231/18 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D413/14
Abstract: The present invention provides pyrazole derived compounds of formula (I) useful for treating p38 kinase-associated conditions, where W, X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and m are as defined herein. The invention further pertains to pharmaceutical compositions containing at least one compound according to the invention useful for treating p38 kinase-associated conditions, and methods of inhibiting the activity of p38 kinase in a mammal.
-
公开(公告)号:DE602008006200D1
公开(公告)日:2011-05-26
申请号:DE602008006200
申请日:2008-07-23
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: LIU CHUNJIAN , WROBLESKI STEPHEN T , LEFTHERIS KATERINA , WU GANG , SHER PHILIP M , ELLSWORTH BRUCE A
IPC: C07D209/42 , A61K31/404
-
公开(公告)号:SI1618092T1
公开(公告)日:2010-11-30
申请号:SI200431517
申请日:2004-05-03
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: DYCKMAN ALARIC , DAS JAGABANDHU , LEFTHERIS KATERINA , LIU CHUNJIAN , ZHAO RULIN , CHEN BANG-CHI , WROBLESKI STEPHEN T
IPC: C07D231/00 , A61K20060101 , A61K31/415 , A61K31/4152 , A61K31/4155 , A61K31/416 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/535 , A61K31/675 , A61P37/00 , C07D20060101 , C07D231/04 , C07D231/14 , C07D231/18 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D413/12 , C07D413/14
-
公开(公告)号:PT1618092E
公开(公告)日:2010-11-22
申请号:PT04751133
申请日:2004-05-03
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: LEFTHERIS KATERINA , WROBLESKI STEPHEN T , DAS JAGABANDHU , LIU CHUNJIAN , DYCKMAN ALARIC , ZHAO RULIN , CHEN BANG-CHI
IPC: C07D231/18 , A61K20060101 , A61K31/415 , A61K31/4152 , A61K31/4155 , A61K31/416 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/535 , A61K31/675 , A61P37/00 , C07D20060101 , C07D231/04 , C07D231/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D413/12 , C07D413/14
-
公开(公告)号:AU2004236240C1
公开(公告)日:2010-11-04
申请号:AU2004236240
申请日:2004-05-03
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: LEFTHERIS KATERINA , ZHAO RULIN , DYCKMAN ALARIC , CHEN BANG-CHI , LIU CHUNJIAN , DAS JAGABANDHU , WROBLESKI STEPHEN T
IPC: C07D231/18 , A61K20060101 , A61K31/415 , A61K31/4152 , A61K31/4155 , A61K31/416 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/535 , A61K31/675 , C07D20060101 , C07D231/04 , C07D231/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D413/12 , C07D413/14
Abstract: The present invention provides pyrazole derived compounds of formula (I) useful for treating p38 kinase-associated conditions, where W, X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and m are as defined herein. The invention further pertains to pharmaceutical compositions containing at least one compound according to the invention useful for treating p38 kinase-associated conditions, and methods of inhibiting the activity of p38 kinase in a mammal.
-
公开(公告)号:AU2004236240B2
公开(公告)日:2010-06-17
申请号:AU2004236240
申请日:2004-05-03
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: LEFTHERIS KATERINA , ZHAO RULIN , DYCKMAN ALARIC , CHEN BANG-CHI , LIU CHUNJIAN , DAS JAGABANDHU , WROBLESKI STEPHEN T
IPC: C07D231/18 , A61K20060101 , A61K31/415 , A61K31/4152 , A61K31/4155 , A61K31/416 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/535 , A61K31/675 , C07D20060101 , C07D231/04 , C07D231/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D413/12 , C07D413/14
Abstract: The present invention provides pyrazole derived compounds of formula (I) useful for treating p38 kinase-associated conditions, where W, X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and m are as defined herein. The invention further pertains to pharmaceutical compositions containing at least one compound according to the invention useful for treating p38 kinase-associated conditions, and methods of inhibiting the activity of p38 kinase in a mammal.
-
公开(公告)号:AT449764T
公开(公告)日:2009-12-15
申请号:AT00988358
申请日:2000-12-22
Applicant: PHARMACOPEIA INC , SQUIBB BRISTOL MYERS CO
Inventor: MORIARTY KEVIN , SHIMSHOCK YVONNE , AHMED GULZAR , WU JUNJUN , WEN JAMES , LI WEI , ERICKSON SHAWN , LETOURNEAU JEFFREY , MCDONALD EDWARD , LEFTHERIS KATERINA , WROBLESKI STEPHEN , HUSSAIN ZAHID
IPC: C07D237/04 , C07D251/42 , A61K31/505 , A61K31/506 , A61K31/53 , A61K31/5377 , A61K31/55 , A61K31/551 , A61K31/56 , A61K45/00 , A61P1/00 , A61P1/04 , A61P1/16 , A61P3/00 , A61P3/10 , A61P7/02 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P11/16 , A61P13/12 , A61P17/00 , A61P17/06 , A61P19/00 , A61P19/02 , A61P19/08 , A61P19/10 , A61P25/00 , A61P25/28 , A61P27/02 , A61P29/00 , A61P35/00 , A61P35/02 , A61P35/04 , A61P37/00 , A61P37/02 , A61P43/00 , C07D239/50 , C07D251/16 , C07D251/44 , C07D251/50 , C07D251/52 , C07D251/54 , C07D251/70 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D487/08 , C07D498/04 , C07D521/00
-
公开(公告)号:PE20080139A1
公开(公告)日:2008-03-10
申请号:PE2007000242
申请日:2007-03-06
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: LIU CHUNJIAN , LEFTHERIS KATERINA , VRUDHULA VIVEKANANDA M , LIN JAMES
IPC: A61K31/53 , A61P29/00 , C07D487/04
Abstract: SE REFIERE A COMPUESTOS DERIVADOS DE PIRROLOTRIAZINA ANILINA DE FORMULA (I), EN DONDE AL MENOS UN X1, X2 O X3 ES R4-O-C(R2)-O-C(=O)-; Y CUALQUIER RESTANTE ES H; EN DONDE R2 ES H O ALQUILO; R4 ES -P(=O)(OH)2, -C(=O)-C(R27)-NH(R28), -C(=O)-C=C-CO2H, ENTRE OTROS; A1 Y A2 SON INDEPENDIENTEMENTE ALQUILO, CICLOALQUILO, ARILO, HETEROARILO, ENTRE OTROS OPCIONALMENTE SUSTITUIDO; R1, R3 Y R5 SON INDEPENDIENTEMENTE H, ALQUILO OPCIONALMENTE SUSTITUIDO, HALOGENO, CIANO, CICLOALQUILO, ENTRE OTROS. SON SELECCIONADOS: FOSFONOOXIMETILCICLOPROPIL(4-METIL-3-(5-METIL-6-(PROPILCARBAMOILPIRROLO-[1,2-f][1,2,4]TRIAZIN-4-ILAMINO)BENZOIL)CARBAMATO, (S)-((4-(5-(CICLOPROPILCARBAMOIL)-2-METILFENILAMINO)-5-METILPIRROLO[1,2-f][1,2,4]-TRIAZIN-6-CARBONIL)(PROPIL)CARBAMOILOXI)METIL 2-AMINOPROPANOATO, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA; ESTOS COMPUESTOS SON INHIBIDORES SELECTIVOS DE LA ACTIVIDAD DE LA CINASA P38, POR LO QUE SON UTILES EN EL TRATAMIENTO DE TRASTORNOS INFLAMATORIOS
-
-
-
-
-
-
-
-
-